In addition, in vivo experiments found that PGG cured cancer cachexia by inhibiting IR and IGF1R in pancreatic cancer cells, thereby reducing glycolytic enzymes, hepatic gluconeogenesis, skeletal muscle protein hydrolysis, and fat lipolysis in tumor grafts. This evidence concerns the gene IGF1R and pancreatic neoplasm.